Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations. N Engl J Med. 2015 Aug 20; 373(8):726-36.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.